Perelman School of Medicine Signs a Research and Development Agreement with Sensus Healthcare for its Sculptura Intraoperative Radiation Therapy System
Shots:
- The Perelman School of Medicine at the University of Pennsylvania & Sensus Healthcare enter into a research & development agreement for Sculptura robotic IORT system
- In Feb’19- Sculptura has received FDA’s market clearance and the University of Pennsylvania is the world’s first University to utilize the technology- enabling the doctors to sculpt exact areas of the body with the radiation beam and tracking of respiratory motion
- Sculptura robotic radiation oncology system involves 3D Beam Sculpting technology- targeting IORT with a single dose to patients undergoing cancer treatment during surgery or at the tumor site. Additionally- Sensus also offers low-energy X-ray platform such as SRT-100- SRT-100+ and SRT-100 Vision systems to treat non-melanoma skin cancers and keloids
Ref: PRNewswire | Image: Medical Product Outsourcing
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com